Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Access

Recombinant human activated protein C: current insights into its mechanism of action

Marcel Levi* and Tom van der Poll

Critical Care 2007, 11(Suppl 5):S3 doi:10.1186/cc6154

Accesses  

  • Last 30 days: 49 accesses
  • Last 365 days: 751 accesses
  • All time: 5472 accesses